Representative Reported Investments in Coal and Opioids
Financial filings reveal holdings in companies facing significant safety and legal scrutiny.
Updated on Oct. 7, 2026 in Public Companies
Live Poll
Should members of Congress be prohibited from owning stocks in industries they regulate?
Representative Virginia Foxx reported holding stakes in pharmaceutical firm AbbVie and coal producer Alliance Resource Partners as of May 2025. These investments coincide with her legislative focus on industry regulatory costs.
Why it matters
For North Carolina operators, the overlap between personal investment portfolios and legislative oversight highlights the importance of transparency regarding potential conflicts in sector-specific regulation. Foxx has previously cited high compliance costs as a primary justification for opposing federal safety rules.
Foxx reported holding up to $100,000 in Alliance Resource Partners, a firm that has accrued over 900 workplace safety penalties since 2000, while also holding up to $50,000 in AbbVie. The total value of her transactions in coal-related stock reached approximately $209,000.
The players
Virginia Foxx
A Representative from North Carolina who chaired the House Education and Workforce Committee.
Alliance Resource Partners
A coal production company that has received over 900 workplace safety penalties since 2000.
AbbVie
A major pharmaceutical firm focused on biopharmaceuticals.
The details
Foxx, who chaired the House Education and Workforce Committee during 2023-2025, actively opposed a silica exposure rule finalized in April 2024. Her committee supported provisions to block federal funding for the enforcement of these safety measures, which industry groups like the National Stone, Sand, and Gravel Association estimated would impose $162 million in compliance costs. Meanwhile, entities like the Mountain View Mine have faced consistent regulatory action, accumulating 827 penalties since 2019.
Timeline
2000: Alliance Resource Partners began accumulating workplace safety penalties.
2019: Mountain View Mine started receiving MSHA penalties.
2022: Allergan settled with North Carolina over opioid allegations.
April 2024: Federal silica rule finalized.
May 2025: Foxx reported AbbVie stock holdings in PFD filing.
Market Landscape
This situation follows a pattern of heightened scrutiny regarding the alignment between federal legislative oversight and personal financial interests. It occurs as the federal silica rule continues to serve as a central point of contention between labor safety advocates and industry groups.
Operators in sectors facing federal oversight should track committee voting records as a proxy for upcoming changes in compliance enforcement. Monitor upcoming legislative sessions to see if proposed funding blocks for safety agencies gain further traction.
The takeaway
Legislative decisions regarding compliance costs can carry significant weight for industry-specific operational overhead. Keep a close watch on committee-level funding votes to determine if new safety mandates, such as the 2024 silica rule, will face future enforcement delays.
Further reading
For broader trends in regulatory compliance, see our reporting on Public Companies.
Source note: This article includes information reported by The Daily Caller.
Live Poll
Should members of Congress be prohibited from owning stocks in industries they regulate?
